期刊文献+
共找到2,802篇文章
< 1 2 141 >
每页显示 20 50 100
New HPLC Method with Experimental Design and Fluorescence Detection for Analytical Study of Antihypertensive Mixture,Amlodipine and Valsartan 被引量:1
1
作者 Tadeusz Inglot Anna Gumieniczek +1 位作者 Paulina Maczka Ewelina Rutkowska 《American Journal of Analytical Chemistry》 2013年第1期17-23,共7页
New HPLC method was developed for determination of amlodipine and valsartan in their binary mixture as a part of routine control of combined formulations. The method was validated to meet official requirements includi... New HPLC method was developed for determination of amlodipine and valsartan in their binary mixture as a part of routine control of combined formulations. The method was validated to meet official requirements including selectivity, stability, linearity, precision and accuracy. Chromatography was carried out using a LiChrospher RP-18 column, a mixture containing acetonitrile, phosphate buffer of pH 3.5 and methanol (45:45:10, v/v/v) and new fluorescence detection at 255 nm for excitation and 448 nm for emission. The effect of methanol content, pH of the buffer, flow rate, detection wavelengths and column temperature was estimated in robustness study, according to a plan defined by the Plackett-Burman design. For identification of significant effects, both graphical and statistical methods were used. Ro-bustness for dissolution test was checked estimating the effects of paddle speed, temperature and pH of dissolution medium. The method was proved to complying with all official guidelines. Therefore, it is suitable for determination of amlodipine and valsartan in their binary mixtures for different analytical and pharmaceutical purposes. 展开更多
关键词 hplc method Fluorescence Detection Experimental Design Amlodipine and Valsartan Binary Mixture
在线阅读 下载PDF
RP-HPLC Method for the Simultaneous Determination of Lisinopril and NSAIDs in API, Pharmaceutical Formulations and Human Serum 被引量:2
2
作者 Najma Sultana M. Saeed Arayne +1 位作者 Rubina Siddiqui Safila Naveed 《American Journal of Analytical Chemistry》 2012年第2期147-152,共6页
High performance liquid chromatographic method was developed valdated and applied for the simultaneous determi- nation of lisinopril and NSAIDs in bulk, pharmaceuticals formulations and human serum. A Purospher star C... High performance liquid chromatographic method was developed valdated and applied for the simultaneous determi- nation of lisinopril and NSAIDs in bulk, pharmaceuticals formulations and human serum. A Purospher star C18 (5 μm, 25 × 0.46 cm) column was used with mobile phase consisting of methanol: water: acetonitrile (80:17.5:2.5 v/v, pH 3.0) and quantitative evaluation was performed at 225 nm with a flow rate of 1.0 mL?min–1. The retention time of lisinopril was 2.2 min while naproxen, flurbiprofen, diclofenac sodium and mefenamic acid were found to be 4.0, 4.5, 5.0 and 6.7 min respectively. Suitability of this method for the quantitative determination of the drugs was proved by validation in accordance with the requirements laid down by International Conference on Harmonization (ICH) guidelines. The method is selective, precise, accurate and can be used for analysis of pharmaceutical preparations in quality control and clinical laboratories. 展开更多
关键词 LISINOPRIL NSAIDS method VALIDATION hplc DETERMINATION
暂未订购
Stability Indicating HPLC Method for Quantification of Solifenacin Succinate &Tamsulosin Hydrochloride along with Its Impurities in Tablet Dosage Form 被引量:1
3
作者 Hari Kishan Reddy Ganthi Raveendra Reddy P +3 位作者 Young Jun Park Hanimi Reddy Bapatu So Jin Park Woo Hyong Cho 《American Journal of Analytical Chemistry》 2016年第11期840-862,共23页
A novel stability-indicating RP-HPLC method was developed and validated for simultaneous determination of Solifenacin Succinate & Tamsulosin Hydrochloride and its impurities in tablet dosage form. The method was d... A novel stability-indicating RP-HPLC method was developed and validated for simultaneous determination of Solifenacin Succinate & Tamsulosin Hydrochloride and its impurities in tablet dosage form. The method was developed using L1 column with gradient using the mobile phase consist of solvent-A (pH = 6.6, phosphate buffer + 0.5% Triethylamine) and solvent-B (90% Acetonitrile). The eluted compounds were monitored at 225 nm. Solifenacin Succinate & Tamsulosin Hydrochloride was subjected to oxidative, acid, base, hydrolytic, thermal and photolytic stress conditions. The developed method was validated as per ICH guidelines with respect to specificity, linearity, limit of detection, limit of quantitation, accuracy, precision and robustness. The limit of quantification results was ranged from 0.135 - 0.221 μg/mL for Solifenacin Succinate impurities and 0.043 - 0.090 μg/mL for Tamsulosin Hydrochloride impurities. This method is suitable for the estimation of impurities and assay of Solifenacin Succinate & Tamsulosin Hydrochloride in tablets dosage form. 展开更多
关键词 SOLIFENACIN TAMSULOSIN RP-hplc IMPURITIES method Validation
暂未订购
Development and Application of a Validated HPLC Method for the Determination of Clindamycin Palmitate Hydrochloride in Marketed Drug Products: An Optimization of the Current USP Methodology for Assay
4
作者 Geoffrey K. Wu Abhay Gupta +1 位作者 Mansoor A. Khan Patrick J. Faustino 《Journal of Analytical Sciences, Methods and Instrumentation》 2013年第4期202-211,共10页
A simple efficient isocratic reversed-phase HPLC method was developed and validated for the determination of clindamycin palmitate hydrochloride (CPH) and its commercially available oral solution products. Separation ... A simple efficient isocratic reversed-phase HPLC method was developed and validated for the determination of clindamycin palmitate hydrochloride (CPH) and its commercially available oral solution products. Separation was achieved on a Phenomenex Zorbax (Luna) cyano column (150 × 4.6 mm, 5 μm) with a Phenomenex cyano guard cartridge (4 × 3.0 mm) on Agilent 1050 series HPLC system. CPH and its resolution standard lincomycin were eluted isocratically at a flow rate of 1 mL/min with a simplified mobile phase (potassium phosphate buffer (5 mM, pH 3.0)—acetonitrile—tetrahydrofuran (20:75:5, v/v/v)) and detected at 210 nm. The column was maintained at 25?C. The method was validated according to USP category I requirements. Robustness and forced degradation studies were also conducted. CPH marketed drug products were obtained from a drug distributor and assayed for potency using the validated method. Validation acceptance criteria were met in all cases. The analytical range for CPH was 15 - 500 μg/mL and the linearity was r2 > 0.999 over three days. The method was determined to be specific and robust. Both accuracy (92.0% - 103.8%) and precision (0.67% - 1.52%) were established across the analytical range for low, intermediate and high QC concentrations. Method applicability was demonstrated by analyzing two marketed products of CPH, in which results showed potency >98%. The method was determined to be an enhancement over the current USP methodology for assay as a result of increased efficiency, reduced organic solvents and the elimination of matrix modifiers. This method was successfully applied for the quality assessment of: 1) currently marketed drug products and 2) will in future assess the product quality of novel dosage forms of CPH for pediatric use. 展开更多
关键词 CLINDAMYCIN PALMITATE HYDROCHLORIDE (CPH) hplc method Validation PEDIATRIC DOSAGE Form
暂未订购
Stability Indicating RP-HPLC Method for Quantification of Impurities in Valsartan and Hydrochlorothiazide FDC Tablet Dosage Form
5
作者 Hari Kishan Reddy Ganthi Raveendra Reddy P +2 位作者 Young Jun Park So Jin Park Woo Hyong Cho 《American Journal of Analytical Chemistry》 2016年第11期816-839,共24页
A stability-indicating RP-HPLC method has been developed and validated for simultaneous determination of Valsartan & Hydrochlorothiazide and their impurities in FDC (Fixed Dose Combination) tablet dosage form. The... A stability-indicating RP-HPLC method has been developed and validated for simultaneous determination of Valsartan & Hydrochlorothiazide and their impurities in FDC (Fixed Dose Combination) tablet dosage form. The method was developed using L1 column (250 × 4.6 mm;5 μm) with gradient elution using the mobile phase consisting of solvent-A (0.1% Ortho phosphoric acid) and solvent-B (100% Acetonitrile);the gradient program (T<sub>min</sub>/%B) was set as 0/10, 5/10, 20/60, 40/60, 41/10 and 50/10. The eluted compounds were monitored at 265 nm. The developed method was validated as per ICH guidelines with respect to specificity, linearity, limit of detection, limit of quantitation, accuracy, precision and robustness. The influence of Acid, Alkaline, Oxidative, Photolytic, Thermal and Humidity stress conditions, on drug product was studied. The limit of quantification results of Valsartan, Hydrochlorothiazide and their impurities are, VAL: 0.303 μg/mL, HCTZ: 0.019 μg/mL, VAL RC-B: 0.085 μg/mL, VAL RC-C: 0.327 μg/mL, HCT RC-A: 0.017 μg/mL, CTZ: 0.080 μg/mL and 5-Chloro HCT: 0.047 μg/mL. The proposed method is suitable for the estimation of Valsartan & Hydrochlorothiazide impurities in tablets dosage form. 展开更多
关键词 VALSARTAN HYDROCHLOROTHIAZIDE RP-hplc IMPURITIES method Validation
暂未订购
Validation of a HPLC Method for Quantification of Thiamine and Its Phosphate Esters in Rat Brain Tissue
6
作者 Polliana Toledo Nunes Patrí +2 位作者 cia da Silva Oliveira Vany Ferraz Angela Maria Ribeiro 《Journal of Behavioral and Brain Science》 2017年第2期79-93,共15页
The present data show a fast and efficient biological sample processing method for the extraction of thiamine (vitamin B1) and its mono-(TMP) and di-(TDP) phosphate esters from hippocampus, thalamus and prefrontal cor... The present data show a fast and efficient biological sample processing method for the extraction of thiamine (vitamin B1) and its mono-(TMP) and di-(TDP) phosphate esters from hippocampus, thalamus and prefrontal cortex (PFC) and blood sample of the rodents. In addition, using the hippocampus and standards of these three compounds we validated an isocratic fluorescence HPLC procedure for a simultaneous detection of them in a single chromatogram within a total run time of about 12 min. Reproducibility for TDP, TMP and B1 was 2.66%, 4.50% and 7.43% (intraday) and 37.54%, 25.39% and 25.87% (interday), respectively. Recovery assays were between 96.0% and 101.7%. The calibration curves were linear and the concentrations of the three compounds, all in nanomolar range, were determined in the brain areas and in the blood samples. When compared to the current methods in the literature, this new method provides information on essential variables, such as linearity range and limit of detection, reproducibility and stability of thiamine, TMP and TDP in rat brain samples. The present data on sample processing and B1 and its phosphate ester level determinations are the first to be validated using hippocampus samples of rats. 展开更多
关键词 THIAMINE hplc Rat BRAIN SAMPLES VALIDATION method
暂未订购
衍生-HPLC法同时检测反应液中丙酮酸和丙酮酸乙酯的含量
7
作者 董明燕 王艳 +3 位作者 赵磊 冯棋赟 高爱红 岳涛 《化学试剂》 2026年第2期66-72,共7页
建立了衍生-高效液相色谱(HPLC)法同时测定丙酮酸反应液中丙酮酸和丙酮酸乙酯含量的分析方法。用抗坏血酸(VC)淬灭样品溶液中过氧化氢,用2,4-二硝基苯肼(DNPH)衍生丙酮酸和丙酮酸乙酯,并考察了淬灭剂(VC)、盐酸溶液、衍生溶液、衍生温... 建立了衍生-高效液相色谱(HPLC)法同时测定丙酮酸反应液中丙酮酸和丙酮酸乙酯含量的分析方法。用抗坏血酸(VC)淬灭样品溶液中过氧化氢,用2,4-二硝基苯肼(DNPH)衍生丙酮酸和丙酮酸乙酯,并考察了淬灭剂(VC)、盐酸溶液、衍生溶液、衍生温度与时间等因素对衍生试验的影响。优化后的色谱条件为:以C18柱为分析柱,以0.1%磷酸溶液和乙腈为流动相,梯度洗脱方式,检测波长为360 nm,以外标法定量。结果表明:丙酮酸和丙酮酸乙酯衍生物的色谱峰与其它色谱峰的分离度>2.0,衍生剂、杂质与溶剂均不干扰目标物测定,方法的专属性良好;在4.50~45.00 mg/L浓度范围内,丙酮酸和丙酮酸乙酯衍生物线性关系良好,相关系数>0.9998;检出限分别为0.00336和0.00387 mg/L,定量限分别为0.0112和0.0129 mg/L;3批次样品的精密度检测结果的相对标准偏差(RSD)值均小于1.5%(n=6),加标回收率范围分别为99.79%~101.31%与98.93%~99.80%;在室温下放置48 h,丙酮酸与丙酮酸乙酯衍生物的峰面积的RSD<1.0%,样品溶液稳定性良好。建立的方法前处理操作简单,检测速度快与准确度高,可用于丙酮酸制备过程中各阶段反应情况的反应监控和产率评估,为工艺优化与生产提供数据支撑。 展开更多
关键词 丙酮酸乙酯 丙酮酸 2 4-二硝基苯肼(DNPH) 衍生-hplc 抗坏血酸
在线阅读 下载PDF
国产法罗培南钠制剂HPLC含量测定方法的优化及统一
8
作者 韩芸 《广州化工》 2026年第2期56-59,共4页
通过优化并统一法罗培南钠制剂(片剂、胶囊剂及颗粒剂)的HPLC含量测定方法,对国产法罗培南制剂含量进行研究探讨。实验采用Welch Ultimate XB-C_(18)色谱柱(4.6 mm×150 mm,5μm),柱温30℃;流动相为磷酸盐缓冲液(含磷酸二氢钾4.8 g... 通过优化并统一法罗培南钠制剂(片剂、胶囊剂及颗粒剂)的HPLC含量测定方法,对国产法罗培南制剂含量进行研究探讨。实验采用Welch Ultimate XB-C_(18)色谱柱(4.6 mm×150 mm,5μm),柱温30℃;流动相为磷酸盐缓冲液(含磷酸二氢钾4.8 g、磷酸氢二钠5.4 g及溴化四丁基铵1.0 g,加水溶解并稀释至1 000 mL)-乙腈-甲醇(75:10:15),流速1.0 mL/min,检测波长305 nm,进样量20μL。结果显示,法罗培南峰与S-异构体峰分离良好;法罗培南在0.06~0.37 mg/mL浓度范围内与峰面积呈良好线性关系;方法精密度、准确度及耐用性均符合分析要求。优化后的方法灵敏度高、分离效果佳、分析时间短,适用于国产制剂的含量测定,可为国产制剂含量统一评价提供参考。 展开更多
关键词 法罗培南钠制剂 含量测定 高效液相色谱法 方法优化 标准完善
暂未订购
HPLC法同时测定制酸止痛胶囊中苍耳草和枳壳化学成分的含量
9
作者 蔡远东 李天佑 +1 位作者 路利亚 陈跃玲 《中国处方药》 2026年第2期33-37,共5页
目的采取高效液相色谱法(HPLC)同时测定制酸止痛胶囊中苍耳草(绿原酸、隐绿原酸)和枳壳(芸香柚皮苷、柚皮苷、橙皮苷、新橙皮苷)化学成分的含量,为该制剂质量标准的提升提供依据。方法以Waters Symmetry^(®)C_(18)5μm,4.6 mm×... 目的采取高效液相色谱法(HPLC)同时测定制酸止痛胶囊中苍耳草(绿原酸、隐绿原酸)和枳壳(芸香柚皮苷、柚皮苷、橙皮苷、新橙皮苷)化学成分的含量,为该制剂质量标准的提升提供依据。方法以Waters Symmetry^(®)C_(18)5μm,4.6 mm×250 mm Column为色谱柱,使用50%甲醇作为提取剂,对样品进行水浴回流提取。以乙腈-0.1%磷酸溶液为流动相,梯度洗脱,流速为1 mL/min,检测波长为272 nm(绿原酸,隐绿原酸)、283 nm(芸香柚皮苷、柚皮苷、橙皮苷、新橙皮苷),柱温为30℃,进样量为10μL。计算其含量。结果线性方程、相关系数和线性范围分别为:绿原酸:y=51358x+1868.1,r=0.9997(n=7),1.00~19.93μg/mL;隐绿原酸:y=55406x-1022.7,r=0.9999(n=7),1.03~20.60μg/mL;芸香柚皮苷:y=6442.2x+202.47,r=0.9999(n=7),1.61~32.24μg/mL;柚皮苷:y=7061.1x-428.58,r=1.0000(n=7),2.93~58.55μg/mL;橙皮苷:y=7014.8x-668.83,r=0.9999(n=7)、1.12~22.39μg/mL;新橙皮苷:y=6999.7x+1124.3,r=1.0000(n=7),3.17~63.33μg/mL,各成分在各自范围内线性关系良好。绿原酸平均回收率:99.95%,相对标准偏差(RSD)为1.2%;隐绿原酸平均回收率:100.17%,RSD为1.2%;芸香柚皮苷平均回收率:100.02%,RSD为0.6%;柚皮苷平均回收率:100.01%,RSD为0.2%;橙皮苷平均回收率:99.82%,RSD为1.9%;新橙皮苷平均回收率:99.84%,RSD为0.4%。结论建立的方法简便、易行,准确度较高,目标成分分离效果较好,可用于制酸止痛胶囊中苍耳草(绿原酸、隐绿原酸)和枳壳(芸香柚皮苷、柚皮苷、橙皮苷、新橙皮苷)目标化学成分的含量测定。 展开更多
关键词 制酸止痛胶囊 hplc 苍耳草化学成分 枳壳化学成分 含量测定
在线阅读 下载PDF
DEVELOPMENT OF A NOVEL HPLC METHOD FOR QUALITY CONTROL OF SAFFRON(CROCUS SATIVUS L.)
10
作者 Kuchta K Jin HH +2 位作者 Wang RW He HH Yao JB 《World Journal of Traditional Chinese Medicine》 2015年第4期92-93,共2页
Saffron,the dried stigma of Crocus sativus L.,findsnumerous applications in TCM.Here,a novel HPLC protocol was established and applied for the analysis of saffron samples,not only from different places of origin but a... Saffron,the dried stigma of Crocus sativus L.,findsnumerous applications in TCM.Here,a novel HPLC protocol was established and applied for the analysis of saffron samples,not only from different places of origin but also from several harvest seasons.One of the main active constituents of saffron,crocin,is also contained in 展开更多
关键词 CROCUS SATIVUS L DEVELOPMENT OF A NOVEL hplc method FOR QUALITY CONTROL OF SAFFRON
原文传递
HPLC法同时测定饲料级酵母培养物中5种活性成分的含量
11
作者 马艳华 《中国饲料》 北大核心 2025年第20期69-72,共4页
本研究旨在建立一种高效液相色谱法(HPLC),同时测定饲料级酵母培养物中5种活性成分(腺苷、尿苷、肌苷、鸟苷、胞苷)含量。饲料级酵母培养物样品经磷酸盐缓冲液(0.05 mol/L,pH 6.0)提取,β-葡聚糖酶辅助水解细胞壁,离心过滤后采用C18反... 本研究旨在建立一种高效液相色谱法(HPLC),同时测定饲料级酵母培养物中5种活性成分(腺苷、尿苷、肌苷、鸟苷、胞苷)含量。饲料级酵母培养物样品经磷酸盐缓冲液(0.05 mol/L,pH 6.0)提取,β-葡聚糖酶辅助水解细胞壁,离心过滤后采用C18反相色谱柱分离,以磷酸盐缓冲液-甲醇为流动相进行梯度洗脱,于254 nm波长下检测,外标法定量。结果表明:5种核苷在0.10~50.00μg/mL浓度范围内线性关系良好(r~2≥0.9990);检出限(LOD)为0.15~0.30 mg/kg,定量限(LOQ)为0.51~1.00 mg/kg;在低、中、高3个加标水平下,平均回收率为85.2%~106.8%,批内相对标准偏差(RSD)为2.1%~8.7%;专属性实验显示空白基质无干扰,目标峰分离度均> 1.5。样品前处理优化表明,50℃水浴酶解30 min时目标成分回收率显著高于10 min和20 min(P<0.05)。对5种市售样品进行检测发现,腺苷含量最高(25.23~30.14 mg/kg),胞苷含量最低(4.83~8.64 mg/kg),所有样品检测RSD≤3.67%。该方法操作简便、灵敏度高、准确性好,适用于饲料级酵母培养物中多种核苷活性成分的日常检测与质量控制。 展开更多
关键词 hplc 酵母培养物 核苷 同时测定 方法验证
在线阅读 下载PDF
HPLC法同时测定千金子中α-亚麻酸和亚油酸的含量
12
作者 陈慧 张珊珊 +4 位作者 王文希 何余杰 王宏 李喆睿 杨涛 《广东化工》 2025年第10期124-126,145,共4页
目的:建立高效液相色谱法(HPLC)测定千金子中α-亚麻酸和亚油酸含量的分析方法。方法:采用岛津Caprisil C18-P色谱柱(250 mm×4.6 mm,5μm);流动相为0.1%磷酸溶液∶乙腈=15∶85;流速为1.0 m L/min;进样体积20μL;柱温35℃;检测波长2... 目的:建立高效液相色谱法(HPLC)测定千金子中α-亚麻酸和亚油酸含量的分析方法。方法:采用岛津Caprisil C18-P色谱柱(250 mm×4.6 mm,5μm);流动相为0.1%磷酸溶液∶乙腈=15∶85;流速为1.0 m L/min;进样体积20μL;柱温35℃;检测波长203 nm;使用外标法定量。结果:在该实验条件下,α-亚麻酸和亚油酸分别在4.8μg/m L~120.0μg/m L(R2=0.9996)、1.1μg/m L~26.5μg/m L (R2=0.9997)的范围内线性关系良好,α-亚麻酸的平均加标回收率为96.50%,相对标准偏差为1.40%,亚油酸的平均回收率为97.22%,相对标准偏差为2.39%。结论:该方法操作简单、重复性好、精密度高,可满足千金子中α-亚麻酸和亚油酸的含量测定。 展开更多
关键词 千金子 Α-亚麻酸 亚油酸 高效液相色谱法 外标法
在线阅读 下载PDF
HPLC法结合Hotelling T^(2)应用于烟用甘草提取物的质量监控 被引量:1
13
作者 李虓虓 杜国荣 +4 位作者 王丽达 杨振民 芦楠 徐同广 蒋成勇 《安徽农业科学》 2025年第3期177-181,共5页
[目的]研究烟用甘草提取物质量监控评价方法。[方法]采用HPLC法定量分析烟用甘草提取物中的14种主要活性成分,应用基于主成分分析(PCA)的多元统计过程控制(MSPC)技术并结合常规理化指标分析和感官评价结果,计算统计量Hotelling T^(2),以... [目的]研究烟用甘草提取物质量监控评价方法。[方法]采用HPLC法定量分析烟用甘草提取物中的14种主要活性成分,应用基于主成分分析(PCA)的多元统计过程控制(MSPC)技术并结合常规理化指标分析和感官评价结果,计算统计量Hotelling T^(2),以3σ为控制上限绘制控制图,对烟用甘草提取物进行质量评价。[结果]基于主要活性成分分析建立的质量监控模型,可以准确判定不同批次烟用甘草提取物质量情况,从客观上反映了产品的内在质量。[结论]该研究可为烟用甘草提取物质量判定提供快速、准确的技术手段,有效保证产品质量稳定性。 展开更多
关键词 烟用甘草提取物 活性成分 hplc Hotelling T 2 质量监控
在线阅读 下载PDF
Development of an HPLC–UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients 被引量:4
14
作者 Nitin Charbe Sara Baldelli +3 位作者 Valeria Cozzi Simone Castoldi Dario Cattaneo Emilio Clementi 《Journal of Pharmaceutical Analysis》 SCIE CAS 2016年第6期396-403,共8页
A new method using high-performance liquid chromatography coupled with ultra violet detection(HPLC–UV)was developed and validated for the simultaneous quantification of atazanavir,dolutegravir,darunavir,efavirenz,etr... A new method using high-performance liquid chromatography coupled with ultra violet detection(HPLC–UV)was developed and validated for the simultaneous quantification of atazanavir,dolutegravir,darunavir,efavirenz,etravirine lopinavir,raltegravir,rilpivirine and tipranavir in human plasma.For the first time we reported here the development and validation of an HPLC–UV assay to quantify the frequently administered 9antiretroviral compounds including dolutegravir and rilpivirine.A simple solid phase extraction procedure was applied to 500 μL aliquots of plasma.The chromatographic separation of the drugs and internal standard(quinoxaline) was achieved with a gradient of acetonitrile and sodium acetate buffer on a C_(18) reverse-phase analytical column with a 25 min analytical run time.Calibration curves were optimised according to the therapeutic range of drug concentrations in patients,and the coefficient of determination(r^2) was higher than0.99 for all analytes.Mean intraday and interday precisions(RSD) for all compounds were less than 15.0%,and the mean accuracy(% deviation from nominal concentration) was also found to be less than 15.0%.Extraction recovery range was between 80% and 120% for all drugs analysed.The solid phase extraction and HPLC–UV method enable a specific,sensitive,and reliable simultaneous determination of nine antiretroviral agents in plasma.Good extraction efficiency and low limit of HPLC–UV quantification make this method suitable for use in clinical trials and therapeutic drug monitoring. 展开更多
关键词 hplc–UV ANTIRETROVIRALS BIOANALYTICAL method validation
暂未订购
HPLC-DAD多波长切换法同时测定清肝化瘀方中9个成分含量 被引量:2
15
作者 郭紫云 杜丽娜 +2 位作者 张秋燕 谢晓暄 杨燕 《中医药导报》 2025年第4期73-76,108,共5页
目的:采用高效液相色谱-二极管阵列检测器(HPLC-DAD)法建立清肝化瘀方多成分含量的测定方法。方法:采用Agela ASB C18色谱柱(5.0μm,4.6 mm×250.0 mm),以乙腈(A)-0.4%磷酸水溶液(B),梯度洗脱0~10 min,5%A~15%A;10~20 min,15%A~20%A... 目的:采用高效液相色谱-二极管阵列检测器(HPLC-DAD)法建立清肝化瘀方多成分含量的测定方法。方法:采用Agela ASB C18色谱柱(5.0μm,4.6 mm×250.0 mm),以乙腈(A)-0.4%磷酸水溶液(B),梯度洗脱0~10 min,5%A~15%A;10~20 min,15%A~20%A;20~45 min,20%A~30%A;45~60 min,30%A~70%A,柱温为25℃,流速为1.0 mL/min,进样量为10μL,检测波长分别为210 nm(0~11 min,丹参素钠)、327 nm(11~24 min,绿原酸、新绿原酸、隐绿原酸)、292 nm(24~35 min,落新妇苷)、286 nm(35~42 min,丹酚酸B)、370 nm(42~60 min,槲皮素、山柰酚)及290 nm(50~52.5 min,柚皮素)。结果:丹参素钠、丹酚酸B、槲皮素、山柰酚、柚皮素、落新妇苷、绿原酸、新绿原酸及隐绿原酸在各自浓度范围内均呈现良好的线性关系,相关系数均大于0.9995,精密度、稳定性、重复性良好,RSD<5.00%。丹参素钠、丹酚酸B、落新妇苷、绿原酸、新绿原酸及隐绿原酸平均加样回收率(n=6)为99.39%~103.43%,RSD<5%。结论:建立的HPLC-DAD法可同时测定清肝化瘀方中9种成分的含量,具有简便、快速、准确等特点。 展开更多
关键词 清肝化瘀方 hplc-DAD法 多成分测定 含量测定
暂未订购
HPLC-UV method for simultaneous determination of irbesartan, candesartan, gliquidone and pioglitazone in formulations and in human serum
16
作者 Agha Zeeshan Mirza 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2018年第4期273-280,共8页
In this study, we reported and validated a novel and sensitive reversed-phase liquid chromatographic method for the simultaneous determination of irbesartan, candesartan, gliquidone and pioglitazone. Separation was pe... In this study, we reported and validated a novel and sensitive reversed-phase liquid chromatographic method for the simultaneous determination of irbesartan, candesartan, gliquidone and pioglitazone. Separation was performed at 230 nm using a mobile phase consisting of methanol–water(90:10, v/v) with a flow rate of 1 mL/min. p H was adjusted to 3.5 with phosphoric acid. The concentration-response relationship was found linear over a concentration range of 5–25 μg/mL for all of the analytes tested. The limits of detection and quantification were 0.83 and 2.78 for irbesartan, 0.30 and 1.01 for candesartan, 1.11 and 3.93 for gliquidone, and 0.41 and 1.41 μg/mL for pioglitazone, respectively. Described method permitted the successful determination of these drugs in human serum. The developed method was simple, rapid, and it did not require extensive sample purification. 展开更多
关键词 CANDESARTAN GLIQUIDONE IRBESARTAN PIOGLITAZONE RP-hplc method development
原文传递
HPLC Determination of the Major Non-protein Amino Acids and Common Biogenic Amines in Lathyrus sativus Using a Novel Extraction Method 被引量:1
17
作者 ZeYiYAN ChengJinJIAO +2 位作者 FengMinLI YongMinLIANG ZhiXiaoLI 《Chinese Chemical Letters》 SCIE CAS CSCD 2005年第5期639-642,共4页
An assay is presented for simultaneously determining 5 biogenic amines and the major non-protein amino acids: the toxin β-N-oxalyl-L-α,β-diaminopropanoic acid (β-ODAP), its isomer α-ODAP and homoarginine in Lathy... An assay is presented for simultaneously determining 5 biogenic amines and the major non-protein amino acids: the toxin β-N-oxalyl-L-α,β-diaminopropanoic acid (β-ODAP), its isomer α-ODAP and homoarginine in Lathyrus sativus extracts using the HPLC system after derivatization with para-nitrobenzyloxycarbonyl chloride (PNZ-Cl). However, it is more worthy of noting that this paper also describes a new extraction method using 0.2 mol/L HClO4. The new method has some advantages: shorter extraction-time, simultaneous extraction of free amino acids and polyamines, better inhibiting the isomerization of β-ODAP to α-ODAP, and so on. 展开更多
关键词 ODAP homoginine hplc biogenic amines new extraction method.
在线阅读 下载PDF
Development and Validation of Stability Indicating RP-HPLC-PDA Method for Tenatoprazole and Its Application for Formulation Analysis and Dissolution Study
18
作者 Sunil R. Dhaneshwar Vaijanath N. Jagtap 《American Journal of Analytical Chemistry》 2011年第2期126-134,共9页
In the present study, comprehensive stress testing of tenatoprazole was carried out according to ICH guide-line Q1A (R2). Tenatoprazole was subjected to stress conditions of hydrolysis, oxidation, photolysis and neutr... In the present study, comprehensive stress testing of tenatoprazole was carried out according to ICH guide-line Q1A (R2). Tenatoprazole was subjected to stress conditions of hydrolysis, oxidation, photolysis and neutral decomposition. Extensive degradation was found to occur in acidic, neutral and oxidative conditions. Mild degradation was observed in basic conditions. The drug is relatively stable in the solid-state. Successful separation of drug from degradation products formed under stress conditions was achieved on a Kromasil C18 column (250 mm × 4.6 mm, 5.0 μ particle size) using methanol: THF: acetate buffer (68:12:20 v/v) pH adjusted to 6.0 with acetic acid as mobile phase, flow rate was 1.0 mL●min–1 and column was maintained at 45°C. Quantification and linearity was achieved at 307 nm over the concentration range of 0.5 - 160 μg●mL–1 for tenatoprazole. The method was validated for specificity, linearity, accuracy, precision, LOD, LOQ and robustness. 展开更多
关键词 Stability indicating RP-hplc-PDA method VALIDATION COLUMN Liquid Chromatography.
暂未订购
左乙拉西坦注射液中有关物质HPLC测定方法的建立
19
作者 丁极武 李恩澳 +1 位作者 陆荣政 刘荣华 《山东化工》 2025年第2期153-156,159,共5页
目的:建立左乙拉西坦注射液中有关物质的HPLC测定方法,并进行方法学验证。方法:Dikma Platisil ODS色谱柱(柱长250 mm,内径4.6 mm,粒径5μm),以质量分数0.1%磷酸水溶液为流动相A,乙腈为流动相B,梯度洗脱,紫外检测器检测,流速1.0 mL/min... 目的:建立左乙拉西坦注射液中有关物质的HPLC测定方法,并进行方法学验证。方法:Dikma Platisil ODS色谱柱(柱长250 mm,内径4.6 mm,粒径5μm),以质量分数0.1%磷酸水溶液为流动相A,乙腈为流动相B,梯度洗脱,紫外检测器检测,流速1.0 mL/min,检测波长205 nm,柱温30℃,进样量20μL。结果:左乙拉西坦与杂质分离度好;方法学验证结果均符合要求。结论:本方法专属性强,灵敏度高,耐用性好,可用于左乙拉西坦注射液有关物质的测定。 展开更多
关键词 hplc 左乙拉西坦注射液 有关物质 方法学验证
在线阅读 下载PDF
HPLC法测定艾拉戈克钠中的有关物质
20
作者 田帅华 李明月 +2 位作者 刘红伟 何苏云 宗在伟 《药学与临床研究》 2025年第2期142-146,共5页
目的:建立艾拉戈克钠原料药有关物质的HPLC测定方法。方法:采用菲罗门Titank C_(18)柱(4.6 mm×250 mm,5μm)对降解杂质和工艺杂质进行定量分析;以10 mmol·L^(-1)磷酸氢二钾溶液(用磷酸调节pH值至6.5)-乙腈(95∶5)和乙腈为流动... 目的:建立艾拉戈克钠原料药有关物质的HPLC测定方法。方法:采用菲罗门Titank C_(18)柱(4.6 mm×250 mm,5μm)对降解杂质和工艺杂质进行定量分析;以10 mmol·L^(-1)磷酸氢二钾溶液(用磷酸调节pH值至6.5)-乙腈(95∶5)和乙腈为流动相,梯度洗脱;检测波长为275 nm。结果:在选定的色谱条件下艾拉戈克钠与各杂质分离良好,各杂质平均回收率均在97.77%至106.1%之间。结论:本法选择性高、重现性好,可作为艾拉戈克钠质量控制的方法。 展开更多
关键词 hplc 艾拉戈克钠 有关物质
暂未订购
上一页 1 2 141 下一页 到第
使用帮助 返回顶部